New variants will pose continued threat, NIAID chief warns By John Bowden, Megan Sheets Dr Anthony Fauci warned at a Senate committee hearing that the US faced an “urgent need” for a so-called super vaccine that would be more effective at preventing new variants of...
By INSTITUT PASTEUR The Omicron variant was detected for the first time in South Africa in November 2021 and has since spread to many countries. It is expected to become the dominant variant within a few weeks or months. Initial epidemiological studies show that the...
Everyone should get a booster shot. In the long run, though, doses every few months aren’t a viable public health strategy, scientists say. By Apoorva Mandavilli A year ago, just two doses of a Covid-19 vaccine — or even one, in the case of Johnson & Johnson’s...
By Abhinav Choubey ~ Originally Published in Journal of Biomolecular Structure and Dynamics ~ Sept 15, 2021 Abstract Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is the cause of Coronavirus Disease (COVID-19) that has resulted in a global pandemic. At...
By Vikas P. Sukhatme ~ Originally published in Frontiers in Pharmacology ~ April 20, 2021 Fluvoxamine is a well-tolerated, widely available, inexpensive selective serotonin reuptake inhibitor that has been shown in a small, double-blind, placebo-controlled, randomized...
Link to PDF
Israel, one of the world’s most vaccinated places, now heads into yet another surge as infections grow exponentially daily. A massive booster program occurred during the late summer and into the fall as breakthrough infections due to the Delta variant raised serious...
— No reduced risk of mechanical ventilation or death by Zaina Hamza Colchicine (Colcrys) didn't benefit patients hospitalized with moderate to severe COVID-19-related pneumonia, researchers found in the COLCOVID randomized trial. Among more than 1,200 COVID-19...
— Group of physician-scientists believes data support authorization for treating COVID-19 by Sophie Putka t took about 4 days for David Boulware, MD, MPH, to write the FDA emergency use authorization (EUA) application for fluvoxamine. Yes, a doctor wrote an EUA...
Paxlovid and molnupiravir were authorized by the US FDA last week, but supplies of Paxlovid are limited while molnupiravir is less effective than hoped By Melody Schreiber An effective and widely available treatment for Covid would be a significant breakthrough for...
The first-of-its-kind treatment, Paxlovid, has been found to be highly protective against severe illness. It could be available within a few days. By Rebecca Robbins and Carl Zimmer The Food and Drug Administration on Wednesday authorized the first pill for Covid-19,...
The communist island of Cuba, long scorned by most of the U.S. political classes that led to ongoing economic sanctions over the past decades, led to the development of a considerable medical sector in this low-and-middle-income country (LMIC). In fact, of all Latin...
Yet another potentially high quality COVID-19 vaccine has been authorized on an emergency use basis by the World Health Organization (WHO). Biotech company Novavax (NASDAQ: NVAX) and Indian partner Serum institute of India (SII) the world’s largest vaccine...
By Helen Branswell With the world facing the latest in a seemingly endless stream of coronavirus variants — and with bullish talk from manufacturers about a need for even more vaccine shots — you wouldn’t be alone if you were wondering: Are Covid boosters...
By Sonia Elijah The highly confidential Pfizer documents, which have been synonymous with the extreme lack of transparency revealed by the actions of pivotal governmental agencies, over the past 20 months, lead critics of the official narrative to demand “show us the...